NCT07243938 2025-11-24
Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET)
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Not yet recruiting
Clinical Trials
10 trialsNCT03843853 2022-07-25
Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2 Withdrawn
NCT01918852 2018-03-14
SALTO
Dutch Colorectal Cancer Group
Phase 3 Completed
NCT00660894 2016-08-03
Tegafur-Uracil and Leucovorin or S-1 in Treating Patients With Stage III Colon Cancer That Has Been Completely Removed by Surgery
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
Phase 3 Completed
NCT01110941 2015-05-19
SCI-101
Peking University
Phase 1/2 Completed
NCT00677443 2013-06-14
Study of S-1 and Oxaliplatin (SOX) Versus Capecitabine and Oxaliplatin (COX) in Patients With Advanced Colorectal Cancer
Samsung Medical Center
Phase 3 Completed
NCT01193452 2010-09-02
S-1/Leucovorin (SL) Versus sLV5FU2 as the First-line Treatment for Elderly Patients With Colorectal Cancer
Fudan University
Phase 2 Unknown
NCT00524706 2008-11-13
Phase I/II Study of SOL for Untreated Metastatic Colorectal Cancer
Shizuoka Cancer Center
Phase 1/2 Unknown
NCT00209651 2007-11-01
Phase II Study of Oral S-1 Plus Irinotecan (IRIS) in Patients With Advanced Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 2 Unknown
NCT00316745 2007-11-01
IRIS Followed by mFOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer
Hokkaido Gastrointestinal Cancer Study Group
Phase 3 Suspended